Receptor-Mediated and Fluid-Phase Transcytosis of Horseradish Peroxidase across Rat Hepatocytes by Ellinger, Isabella & Fuchs, Renate
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 850320, 8 pages
doi:10.1155/2010/850320
Research Article
Receptor-Mediated andFluid-Phase Transcytosisof
Horseradish Peroxidase across Rat Hepatocytes
IsabellaEllingerand RenateFuchs
Department of Pathophysiology, Medical University of Vienna, W¨ ahringer G¨ urtel 18-20, 1090 Vienna, Austria
Correspondence should be addressed to Renate Fuchs, renate.fuchs@meduniwien.ac.at
Received 3 August 2009; Revised 11 October 2009; Accepted 4 November 2009
Academic Editor: Xue-Ru Wu
Copyright © 2010 I. Ellinger and R. Fuchs. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Horseradish peroxidase (HRP) is often used as a ﬂuid-phase marker to characterize endocytic and transcytotic processes. Likewise,
it has been applied to investigate the mechanisms of biliary secretion of ﬂuid in rat liver hepatocytes. However, HRP contains
mannose residues and thus binds to mannose receptors (MRs) on liver cells, including hepatocytes. To study the role of MR-
mediated endocytosis of HRP transport in hepatocytes, we determined the inﬂuence of the oligosaccharid mannan on HRP biliary
secretion in the isolated perfused rat liver. A 1-minute pulse of HRP was applied followed by marker-free perfusion. HRP appeared
in bile with biphasic kinetics: a ﬁrst peak at 7 minutes and a second peak at 15 minutes after labeling. Perfusion with 0.8mg/mL
HRP in the presence of a twofold excess of mannan reduced the ﬁrst peak by 41% without eﬀect on the second one. Together with
recently published data on MR expression in rat hepatocytes this demonstrates two diﬀerent mechanisms for HRP transcytosis: a
rapid, receptor-mediated transport and a slower ﬂuid-phase transport.
1.Introduction
The liver plays a major role in the secretion of macro-
molecules into bile either by receptor-mediated or unspeciﬁc
ﬂuid-phase transcytosis. Although the liver is composed
of parenchymal (hepatocytes) and nonparenchymal cells
(endothelial cells, Kupﬀer cells, Ito cells), only hepatocytes
are involved in bile formation and biliary secretion of blood-
derived molecules. As isolated hepatocytes in culture do not
form a polarized epithelial layer where the apical and baso-
lateral surfaces are accessible at opposite sides, transcytosis
studies are conﬁned to in vivo experiments or to the isolated
perfused rat liver [1, 2]. Using the latter system, biliary
secretion of various ligands taken up by receptor-mediated
and/or ﬂuid-phase endocytosis has been investigated so far.
In contrast to other polarized epithelial cells (intestine,
kidney, placenta) receptor-mediated endocytic processes are
mainly conﬁned to the basolateral (sinusoidal) surface of
hepatocytes [1]. One of these sinusoidal receptors is a recep-
tor for galactose-containing glycoproteins, so-called asialo-
glycoproteins. This galactose receptor or asialoglycoprotein
receptor (ASGPR) clears defective asialoglycoproteins (e.g.,
asialoorosomucoid; ASOR) from the circulation by receptor-
mediated endocytosis. The receptors recycle and ASOR is
directed to lysosomes for degradation. However, about 0.5–
3% of internalized ASOR is missorted into the transcytotic
route and consequently secreted intact into bile [3, 4].
Interestingly, the kinetics and amount of biliary secretion
of diﬀerent ﬂuid-phase markers such as inulin or dextrans
(MW2–70kDa)diﬀerconsiderably,aneﬀectthatisgenerally
attributed to their diﬀerent molecular weight and/or charge
[5, 6]. Even more surprising, horseradish peroxidase (HRP),
following short pulse labeling, has a biphasic appearance
in bile: the ﬁrst, faster peak is assumed to occur by a
paracellular route, while the second, slower peak takes place
by transcytosis [7]. Transcytosis of the latter peak has been
demonstrated by its complete absence in the presence of
microtubule depolymerizing drugs [8]. With respect to
the fast HRP appearance in bile the following data argue
against a paracellular pathway: we have previously shown
that low-temperature perfusion (16◦C) results in a delayed
appearance of the ﬁrst peak in bile as compared to perfusion
at 37◦C[ 9]. Furthermore, 2 minutes after HRP loading HRP
containingvesicleswereseeninthevicinityofthecanalicular2 Journal of Biomedicine and Biotechnology
membrane [7]. Moreover, HRP is not an ideal ﬂuid-phase
marker as it is a mannose-containing glycoprotein and thus
binds to mannose receptors (MR) on hepatic Kupﬀer and
endothelial cells with high aﬃnity [10–12]. In addition, HRP
binds with low aﬃnity (Km ∼4μM) to isolated hepatocytes
[11,13]andinthesecellsHRPuptakeupto0.2mg/mLcould
be competed by mannan, indicative for receptor-mediated
endocytosis via an MR. To study the potential role of hepatic
MR on HRP biliary secretion we determined the inﬂuence
of the mannose oligosaccharide mannan (MW ∼100kD) on
HRP transport in the isolated perfused rat liver.
2.MaterialsandMethods
2.1. Animals. Male Louvain rats (250–300g) were obtained
from a local breeding farm and were kept under a controlled
lighting schedule with a 12-hour dark period. Animals had
free access to food and water but were fasted overnight
before the experiment. Before surgical procedures, rats were
anesthetized by an intraperitoneal injection of urethane
solution (1mL/100g body-weight).
2.2. Materials. All chemicals were purchased from Sigma
Chem. Co (Vienna, Austria). FITC-dextran (70kDa) was
extensively dialyzed against Tris-buﬀered saline (pH 7.34)
and ﬁnally against phosphate-buﬀered saline (pH 7.4) before
use. Asialoorosomucoid (ASOR) was obtained by enzymatic
desialylation of α1-acid glycoprotein [14]. ASOR was iodi-
nated in the presence of iodogen (Pierce)to a speciﬁc activity
of approximately 1,4 × 106 cpm/μgA S O R .
2.3. Biliary Secretion of Markers in the Isolated Perfused Rat
Liver. Following surgical removal, isolated rat livers were
equilibrated for 30 minutes at 37◦C by single-pass perfusion
with Krebs-Henseleith bicarbonate buﬀer (KHB; containing
10mMglucoseand20μMtaur oc holicacidandgassedwitha
humidiﬁed mixture of 93% O2/7% CO2,p H7 . 4 )a tap e r f u -
sion rate of 3mL/min and g liver [15, 16]. Biliary secretion of
the respective marker was analyzed by single-pass perfusion
at 37◦C. HRP (0.08mg/mL, 0.8mg/mL or 8mg/mL KHB)
or FITC-dextran (5mg/mL KHB) was perfused through the
liver for 1 minute at 37◦C followed by marker-free perfusion
for 40 minutes. Where indicated, a twofold access of mannan
over HRP was included in the perfusion buﬀer. Single bile
drops were collected and analyzed for the respective marker
concentration. To determine the kinetics of biliary secretion
of 125I-ASOR at 37◦C, the liver was perfused for 2 minutes
with 125I-ASOR (1.3–2.3 × 105 cpm/mL KHB) followed by
marker-free perfusion for 40 minutes. Single bile drops were
collected and TCA-precipitable (intact ASOR) and TCA-
soluble (degraded ASOR) counts in each bile drop were
determined.
2.4. Marker Determination. FITC-ﬂuorescence of FITC-
dextran per biledrop was measured in a spectroﬂuorometer
(FP-777,Jasco,Japan)using495nmand515nmasexcitation
and emission wavelengths, respectively. After subtraction
of background ﬂuorescence, values were converted to con-
centration (pg FITC-dextran/biledrop) with the help of a
calibration curve. The enzymatic activity of HRP per bile
drop was determined based on standard curve according
to Marsh et al. [17]. Following perfusion with 125I-ASOR
single bile drops were subjected to precipitation with 10%
TCA(ﬁnalconcentration)andaftercentrifugation(1500×g,
15 minutes) radioactivity in the supernatant (TCA soluble
degradation products) and pellet (TCA precipitable, i.e.,
intact 125I-ASOR) were determined by γ-counting (1282-
Compugamma CS, LKB).
2.5. Calculations. The bile ﬂow was calculated by determin-
ing the time when each bile drop was formed normalized
to 1g liver (bile ﬂow in μL/min and g liver). The amount
of marker/bile drop was determined using the respective
calibration curve (HRP, FITC-dextran) or radioactivity. As
one bile drop corresponds to 8μL bile, these data were
converted to marker secretion (amount of marker/min and g
liver) by division by 8 and multiplication with the respective
bile ﬂow. The appearance of the marker in bile was corrected
for the dead space of the bile duct cannula. The cummulative
HRP secretion was obtained by summing up the amount
of HRP/bile drop over time. To analyze diﬀerences between
the ﬁrst and the second peak of HRP secretion, we deﬁned
the cumulative amount that was secreted between 0 and
10 minutes to correspond to the 1st HRP peak (secretion
maximum 6–8 minutes). This amount was then subtracted
from the total amount of HRP secreted within 40 minutes to
obtain the total amount secreted during the 2nd HRP peak
(secretion maximum 15 minutes).
3. Results
3.1. Kinetics of Biliary Secretion of the Fluid-Phase Marker
FITC-Dextran and the Ligand, Asialoorosomucoid (ASOR).
For comparison, the secretion kinetics of a bona ﬁde ﬂuid-
phase marker, FITC-dextran, and a galactose-terminated
ligand, asialoorosomuciod (ASOR), were analyzed. FITC-
dextran (MW 70kDa; 5mg/mL) was added to the perfusate
and perfused through the liver for 1 minute (= pulse) under
single-pass conditions. To maintain constant bile ﬂow 20μM
taurocholic acid was always included in the perfusion buﬀer.
Perfusion was then continued in the absence of marker for
up to 40 minutes. The concentration of the marker was
analyzedinsinglebiledropsanddatawererelatedtobileﬂow
and normalized to 1g liver. As shown in Figure 1(a),F I T C -
dextran appeared in bile 4 minutes after marker addition to
theperfusate.Thesecretionrateincreasedwithtimereaching
ap e a ka t8m i n u t e sa n dt h e nd r o p p e dt o0a t4 0m i n u t e s .
The bile ﬂow (Figure 1(b)) revealed a transient decrease
and subsequent increase when the perfusion medium was
changed but then remained constant at about 1.75μL/min
and g liver throughout the perfusion indicative for suﬃcient
oxygen supply, ATP generation, and intact liver function
[16].
125I-ASOR was used as high aﬃnity ligand for the
ASGPR. ASOR is rapidly and eﬃciently taken up fromJournal of Biomedicine and Biotechnology 3
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Figure 1: Kinetics of biliary secretion of FITC-dextran (a) and ASOR (c). Livers were isolated and following 30-minute perfusion, FITC-
dextran (5mg/mL) or
125I-ASOR was administered in the perfusion medium (KHB) for 1 minute and 2 minutes, respectively, at 37◦C( t i m e
0)followedbyasingle-passperfusionwithmarker-freeKHBat37◦C.(a)SinglebiledropswerecollectedandtheFITC-dextranconcentration
was determined using a calibration curve. Data were converted into secretion (ng FITC-dextran/min and g liver). In (b) the corresponding
bile ﬂow is shown (mean ± SD from two (a, b) perfusions). (c) Single bile drop were subjected to precipitation with 10% TCA. Secretion
of intact ASOR (TCA precipitable counts) and degradation products (TCA soluble counts) of one typical experiment out of six are shown.
(d) Corresponding bile ﬂow.
the perfusate and after ligand-receptor dissociation in early
e n d o s o m e st h er e c e p t o ri sr e c y c l e da n dA S O Ri ss o r t e dt o
lysosomes [18, 19]. The appearance of ASOR degradation
products in bile reﬂects the kinetics of arrival in lysosomes.
About 90% of ASOR degradation products are released
into the perfusate and the remainder into bile [3]. Since
0.5%–3% of internalized ASOR is missorted and secreted
intactintobile,determinationofTCA-precipitableandTCA-
soluble radioactivity in bile correlates with transcytosis and
transport to lysosomes, respectively [3, 4]. Biliary secretion
of ASOR at 37◦C was analyzed following a 2-minute pulse
of 125I-ASOR with subsequent marker-free perfusion of the
liver. Single bile drops were collected and TCA-precipitable
(intact) and TCA-soluble (degraded) radioactivity therein
were determined (Figure 1(c)). Intact 125I-ASOR appeared
in bile within 6 minutes after the pulse, while maximum
biliary secretionwasfoundabout17minutes afteruptake. 15
minutes after internalization TCA-soluble counts appeared
in bile, corresponding to ASOR arrival in lysosomes, imme-
diate degradation and release of degradation products into
the perfusate (not shown; [3, 4]) and bile. The bile ﬂow
(Figure 1(d)) remained constant at 1.8μL/g liver and min
throughout this perfusion. Taken together, biliary secretion
of the ﬂuid-phase marker FITC-dextran is faster than the
ligand ASOR.
3.2. Kinetics of Biliary Secretion of HRP and the Eﬀect of Man-
nan on HRP Secretion. HRP (0.8mg/mL KHB) was added
to the perfusion medium for 1 minute followed by marker-
free perfusion (Figure 2(a)). Although HRP appeared in bile
roughly at the same time as FITC-dextran, the secretion
rate revealed two peaks at 7 minutes and 15 minutes,
respectively. These two peaks were seen irrespective of the
HRP concentration perfused through the liver (0.08; 0.8;
8mg/mL) and are in agreement with data from diﬀerent lab-
oratories [7, 8, 20, 21]. The bile ﬂow, shown in Figure 2(b),
remained constant at 1.6μL/g liver and min throughout this
perfusion. The cumulative secretion is shown in Figure 2(c).
Comparison of HRP secretion with secretion of FITC-
dextran and ASOR revealed that HRP exhibits a similar
kinetics as the ﬂuid-phase marker (1st HRP peak) as well as
that of the ligand (2nd HRP peak).
Next, we analyzed the inﬂuence of 1.6mg/mL man-
n a no nH R Ps e c r e t i o n( Figure 3). Similar to the absence
of mannan (compare to Figure 2)t w op e a k so fs e c r e t e d
HRP were seen, at about 8 minutes and 16 minutes,
respectively (Figure 3(a)). The bile ﬂow was maintained
at about 1.5μL/min and g liver (Figure 3(b)). Figure 3(c)
demonstratesthatthetotalcumulativesecretionwasreduced
in the presence of mannan as compared to its absence
(compare to Figure 2(c)). To diﬀerentiate whether mannan4 Journal of Biomedicine and Biotechnology
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Figure 2: Kinetics of biliary secretion of HRP in the absence of
mannan in the perfused rat liver. Isolated livers were perfused with
HRP (0,8mg/mL) for 1 minute at 37◦C( t i m e0 )f o l l o w e db ya
singlepassperfusionwithmarker-freeKHBat37◦C.Theamountof
HRP in single bile drops was determined and the secretion rate was
calculated (a) based on the bile ﬂow (b). Data shown are the mean
± SD ﬁve perfusions. (c) The total amount of HRP (cummulative
HRPsecretion)secretedintobileasafunctionoftheperfusiontime
is shown.
inﬂuenced rather the ﬁrst or the second peak, the amount
of HRP being secreted between 0 and 10 minutes (i.e.,
during the fast, ﬁrst peak) and between 10 minutes and 40
minutes (i.e., during the slow, second peak) was analyzed.
As depicted in Figure 4, the ﬁrst HRP peak was reduced
by 41% by mannan without any inﬂuence on the second
peak.WhenHRPat0.08mg/mLwasappliedintheperfusate,
the ﬁrst peak was also decreased by mannan by 32% while
the second peak was slightly increased by 14% (data not
shown). However, due to the low HRP concentration in
single bile drops individual experiments varied considerable.
When the HRP concentration in the perfusate was raised to
8mg/mL,nosigniﬁcanteﬀectof16mg/mLmannancouldbe
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Figure 3: Eﬀect of mannan on biliary HRP secretion. Livers were
isolatedandfollowing30minutesperfusion,HRP(0,8mg/mL)plus
1.6mg/mL mannan was administered in the perfusion medium
(KHB) for 1 minute at 37◦C (time 0) followed by single-pass
perfusion with marker-free KHB at 37◦Cf o r4 0m i n u t e s .T h e
amount of HRP in single bile drops was determined and the
secretion rate was calculated (a) based on the bile ﬂow (b). Data
shown are the mean ± SD of four perfusions. (c) The total
amount of HRP (cummulative HRP secretion) secreted into bile as
a function of the perfusion time is shown.
seen (data not shown). These data demonstrate that the fast
pathway of HRP entry into bile has to occur at least in part
by a receptor-mediated transcellular route. Nevertheless, the
kinetics of this route clearly diﬀers from that of the ligand
ASOR (see Figure 1(c)).
4. Discussion
4.1. Characteristics of Liver MR. In our study, we have
observed an eﬀect of mannan on the ﬁrst peak of HRP-
secretion that indicates an interaction of HRP with MR
on hepatocytes. The MR (180kDa) was ﬁrst isolated fromJournal of Biomedicine and Biotechnology 5
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Figure 4: Eﬀect of mannan on cumulative HRP secretion. The
cumulative secretion from the experiments shown in Figure 2
(absence of mannan) and Figure 3 (presence of mannan) was cal-
culated for 0–10 minutes (1st peak) and 10–40 minutes (2nd peak).
Data shown are the mean ± SEM from ﬁve and four perfusions,
respectively. Note that only the ﬁrst peak (0–10 minutes) was
reduced in the presence of mannan. Asterisk indicates signiﬁcant
diﬀerences at P ≤ .05.
rat liver Kupﬀer cells [22] and binds glycoproteins with,
for example, terminal mannose or fucose groups in a Ca-
dependent manner. The MR is found on monocyte-derived
and tissue macrophages, cultured dendritic cells, on hepatic
sinusoidal and lymphatic endothelial cells in the small
intestine [23]. Its main function is the clearance of many
serum glycoproteins, lysosomal enzymes, and denatured
collagen containing the respective sugar moieties resulting
in their rapid degradation [24–28]. Rat liver endothelial
cells exhibit a high MR surface density and high aﬃnity
(Km about 30–60nM) for ligands such as ovalbumin [28]
or N-acetylglucosamine containing glycoproteins [29]. MRs
are taken up by clathrin-mediated endocytosis due to a
conserved lysine residue and a dihydrophobic motif in
their short cytoplasmic tail [30, 31]. Internalized MR-
ligand complexes dissociate in the low pH environment of
endosomes [32] resulting in receptor recycling and ligand
transport to and degradation in lysosomes [28, 30].
Apart from being localized to Kuppfer and endothelial
cells receptors for mannose containing glycoproteins were
also described in liver parenchymal cells [11, 33]. Quantita-
tive data from electron microscopy autoradiographic studies
revealedthataminorfractionofmannose-terminatedRNase
was found in hepatocytes [34]. Similarly, aglycerase was
taken up by hepatocytes in a mannose-dependent fashion
[35]. Using mannosylated gold particles, Kempka and Kolb-
Bachofen demonstrated binding of the marker in coated
pits followed by uptake, transcytosis, and secretion into
bile by rat hepatocytes in situ [12]. Although these events
in hepatocytes were rare as compared to liver sinudoidal
cells, they were not completely absent. Using isolated liver
parenchymal cells, binding, uptake, and intracellular routing
tolysosomesofinvertasewasshownthatcouldbeblockedby
mannose [36]. Collectively, these data support the presence
of an MR on the sinusoidal surface of rat hepatocytes.
However, the MR on hepatocytes is clearly distinct from
the MR on Kupﬀer and endothelial cells and has not been
identiﬁed, so far. Antibodies speciﬁc for the 180kDa MR
on endothelial cells did not reveal a protein with similar
molecular weight in hepatocytes [37]. Binding of HRP
to isolated hepatocytes at 4◦Cw a so fl o wa ﬃnity thus
preventing the identiﬁcation of a speciﬁc plasma membrane
protein [13]. However, HRP uptake at 37◦C was saturable
with a Km of 8.3mg/L and could be inhibited by mannan
with an apparent Ki of 2.5mg/L [13] clearly demonstrating
the involvement of MR in HRP endocytosis in hepatocytes.
4.2. Endocytic Compartments Involved in Receptor-Mediated
and Fluid-Phase Transcytosis. Receptor-mediated endocy-
tosis can take place via clathrin-coated pits and vesicles
(e.g., ASOR, polymeric IgA), via caveolae (e.g., albumin in
endothelial cells), and other less characterized mechanisms
[38, 39]. The prevalence of the respective uptake mech-
anism depends on the ligand and cell type. Irrespective
of the uptake mechanism by which each endocytic vesicle
is formed, it contains extracellular ﬂuid and extracellular
material (proteins, ions, etc.). Consequently, ﬂuid-phase
endocytosis occurs concomitantly with receptor-mediated
endocytosis. However, the contribution of distinct endocy-
tosis mechanisms to ﬂuid-phase uptake depends on the cell
type under investigation. The kinetics of transfer of diﬀerent
markers, be they ligands or ﬂuid-phase markers, do not
necessarily allow a prediction of their intracellular route.
FITC-dextran (ﬂuid phase marker) and ASOR (ligand)
utilize the same endocytic subcompartments on their tran-
scellular route from the sinusoidal to the canalicular plasma
membrane [40]. This has been shown by low-temperature
(16◦C) perfusion of isolated perfused rat livers and by
subcellular liver fractionation [40]. Under this condition
FITC-dextran and ASOR accumulate in early endosomes
resulting in inhibition of transcytosis of both molecules and
inhibition of lysosomal degradation of ASOR. Nevertheless,
they are secreted into bile with completely diﬀerent kinetics
(Figures 1(a) and 1(c)).
Similar to the transcytosis of ASOR and FITC-dextran,
low-temperature perfusion blocks the slow pathway of HRP
secretion indicative for involvement of the same endocytic
compartments (early endosomes) during transport to the
canalicular membrane. Consequently, a part of HRP has to
be taken up into typical early endosomes (that accumulate
marker at 16◦C), is then directed into transcytotic vesicles,
and appears in bile at about 15 minutes (Figure 5). In
contrast, a proportion of HRP is internalized via an MR
(mannancompeteableuptake)intoendocyticcompartments
distinct from ASOR-containing endosomes. Such a distinct
fast transcellular pathway is supported by the observation
that HRP appearance in bile during 16◦Cp e r f u s i o ni s
only delayed but not blocked [9] and that HRP-containing
endosomes are observed within 2 minutes in the vicinity
of the canalicular membrane [7]. Evidence for distinct
internalization pathways has also been obtained for other
biliary secreted markers. Albumin and ASOR have been
localized in distinct endocytic compartments early after
uptake in isolated hepatocytes at low temperature [41].
It is still a matter of debate whether the fast HRP
appearance in bile is (additionally) due to paracellular
transport as supported by stimulation of this peak under6 Journal of Biomedicine and Biotechnology
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Figure 5: Scheme of potential pathways involved in HRP secretion
intobile.CompartmentslabeledbyHRPareindicatedbybluecolor.
Although HRP is also directed to lysosomes, only those endosomes
involved in transcytosis are shown in blue. MRs (yellow bars)
presumably recycle back to the sinusoidal plasma membrane.
postcholestatic conditions and by reagents that lead to intra-
hepatic cholestasis [8, 9, 42]. All these treatments increase
the permeability of the tight junctions and could therefore
explain the stimulatory eﬀect on the ﬁrst HRP peak [42, 43].
However, the data presented in this investigation clearly
demonstrate that a least part of the ﬁrst HRP peak is reduced
by mannan and is thus accounted for by receptor-mediated
transcytosis. It may be speculated that mannan reduces the
paracellular permeability. However, since mannose receptors
are only involved in the binding and subsequent endocytosis
of mannose containing glycoproteins to/into cells, it can be
assumed that mannan has no inﬂuence on the paracellular
permeability, though this has not been proven. We cannot
think of an experimental setup to unequivocally diﬀerentiate
between the proportion of the transcellular and paracellular
partofthe1stpeak.Suchasetupisrequiredtodeterminethe
eﬀect of mannan treatment on the paracellular permeability.
4.3. Actual HRP Concentration in the Perfusate. Kuppfer
cells and endothelial cells have an up to 10-times higher
endocytic activity of ﬂuid-phase marker uptake per se [34,
35, 44] and, in addition, mannose-containing glycoproteins
are internalized by high aﬃnity MR into endothelial cells
at a very fast endocytic rate [28, 45]. Consequently, the
actual HRP concentration that will be in contact with
hepatocytes in the isolated perfused rat liver is unknown.
It can be assumed to be much lower as the amount of
HRP added to the perfusion buﬀer due HRP removal
by endothelial and Kupﬀer cells. This may explain the
discrepancies between our results and data by Yamaguchi
et al. [13]. These authors observed saturation of HRP
uptake in isolated hepatocytes already at 0.2mg/mL HRP.
In contrast, we could demonstrate mannan inhibitable HRP
secretion at 0.8mg/mL. Thus, when HRP is applied at
concentrations ranging between 1mg/mL and 10mg/mL
as in morphological and perfusion studies [7, 8, 20, 21,
46] the proportion due to receptor-mediated endocytosis
cannot be ignored, although at such HRP concentrations
uptake by isolated hepatocytes is mainly by a ﬂuid-phase
mechanism.
4.4. Role of Hepatocytes and the Biliary Epithelium in Bile
Formation and Composition. Bile is produced by hepatocytes
at their canalicular surface due to activity of many solute
transporters [47]. The main bile constituent is water (about
96%). The remainder is composed of bile acids (67%),
phospholipids (22%), cholesterol (5%), and proteins (5%).
The canalicular bile then passes through the bile ducts
and is collected in the gallbladder for regulated secretion
into the intestinal tract [48]. Ductular epithelial cells
modify the canalicular bile by a series of secretory and
reabsorptive processes resulting in its alkalinization and
concentration. Thus, ductular/gallbladder bile has a lower
water content (about 87%) and a higher concentration of
all the constituents listed above as canalicular bile. Many
biliary proteins (polymeric IgA) are secreted via receptor-
mediated transcytosis while others (albumin, IgG) reach
bile by a ﬂuid-phase mechanism. Though it has been
shown that the total protein concentration is higher in
ductular/gallbladder than in canalicular bile due to water
absorption, additional absorptive/secretory processes may
aﬀect the concentration of individual proteins [49]. With
respect to HRP we may speculate that this marker is
endocytosed by ductular cells by a ﬂuid-phase mechanism as
shown in isolated rat bile duct epithelial cells [50, 51]. Such
processes may result in a reduction of the amount of HRP
in ductular bile. Thus, the actual amount of HRP secreted
by hepatocytes may be higher. How ductular endocytosis
may aﬀect the concentration of the ﬁrst and second HRP
peak is unknown and cannot be taken into consideration.
In any case, we here demonstrate that HRP secretion in
the isolated perfused rat liver can be inhibited by mannan
indicative for the involvement of MR in HRP uptake by
hepatocytes.
5. Conclusions
The potential pathways for HRP secretion into bile are
summarized in Figure 5: (1) a receptor-mediated, fast,
transcellular route, (2) a slow, ﬂuid-phase transcytotic route
and (3) most likely also a fast paracellular route that is
increased by intra- and extrahepatic cholestasis. Based on
previous data [8, 52] the slow pathway is identical to
that taken by polymeric IgA and ASOR, that is, clathrin-
mediated uptake into early endosomes where sorting into
transcytotic vesicles takes place followed by biliary secretion.
This pathway is blocked by 16◦C in early endosomes and is
entirely dependent on microtubules [8, 9, 52]. In contrast,
the fast transcellular route is microtubule-independent and
insensitive to inhibition by low temperature [8, 9]. This
pathway may involve clathrin-coated pits and vesicles similar
to the uptake of mannose containing glycoproteins in
dendritic cells [53].Journal of Biomedicine and Biotechnology 7
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